Physician profile
Judith E Jones
NPI 1295834307
$4,855.18
in general payments reported to CMS, 2019-2025
14 companies · $289 in 2025
The $289 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,028 · 2022: $1,378 · 2023: $1,291 · 2024: $868 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,448.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,569.02 | 2021-2024 | Xarelto |
| Amgen INC. | $1,015.03 | 2021-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $796.82 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $510.65 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $489.44 | 2021-2024 | Farxiga |
| Pfizer INC. | $159.65 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $129.98 | 2021-2024 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.88 | 2023-2024 | Jardiance |
| Abbott Laboratories | $34.11 | 2022-2024 | Jot Dx |
| Boston Scientific Corporation | $28.94 | 2023 | Watchman Access System |
| Novo Nordisk INC | $22.71 | 2025 | Ozempic |
| Scpharmaceuticals INC. | $21.98 | 2023 | |
| Teleflex LLC | $21.96 | 2024 | Twin-Pass |
| Edwards Lifesciences Corporation | $17.01 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.